SBIR/STTR Research Award
SBIR Phase I: Engineering probiotic yeast to treat hyperuricemia and gout
Award amount
$224,840Program and phase
SBIR · Phase IAward year
2020Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- UNLOCKED LABS INC.
- Proposal award date
- 2020-07-01
- Contract end date
- 2021-06-30
- UEI
- HE5AH1LKAUA3
- Solicitation number
- Not reported
- Topic code
- BT
Research abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be the development of an engineered probiotic as an treatment for hyperuricemia and gout. Acute gout episodes cause debilitating pain and hypers
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Oxalate Biodegrading Probiotic for Kidney Stone Prevention
- Constitutive oxalate-biodegrading Bacillus subtilis for kidney stones
Research funding history
3 SBIR/STTR records share this UEI (2020–2024). Reported award amounts total $2,281,482. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation